STAAR Surgical up 5% in New York as China rebound is in focus after Alcon deal
STAAR Surgical shares were up 5% in New York. The China rebound is being watched after the company ended its deal with Alcon. STAAR Surgical shares jumped over 5% Thursday. The stock extended its volatile rebound as investors focused again on signs of a strong Q1 recovery in China for the implantable eye lens maker.